Leveraging serologic testing to identify children at risk for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER program

Year of Publication:

Categories of Publication:

Lay Abstract and Manuscript Citation:

Mejias A, Schuchard J, Rao S, Bennett TD, Jhaveri R, Thacker D, Bailey LC, Christakis DA, Pajor NM, Razzaghi H, Forrest CB, Lee GM. Leveraging serologic testing to identify children at risk for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER program. J Pediatr. 2023 Feb 21:S0022-3476(23)00117-8. doi: 10.1016/j.jpeds.2023.02.005. Epub ahead of print. PMID: 36822507; PMCID: PMC9943558

DOI: 10.1016/j.jpeds.2023.02.005

The lay abstract for this publication was generated using an AI model and reviewed by the lead author and the PEDSnet Engagement Core team.

Publication

Leveraging serologic testing to identify children at risk for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER program

Year of Publication:

Categories of Publication:

Lay Abstract and Manuscript Citation:

Find publication:

Related Publications

SSRI/SNRI and long COVID in children and adolescents with neuropsychiatric conditions: a cohort study from the RECOVER Initiative

Pre-COVID-19 body mass index and post-acute cardiovascular, gastrointestinal, and neuropsychiatric outcomes among children and young adults with SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER Initiative

Evaluation of steroids for acute COVID in the prevention of long COVID in children: an EHR and pediatric cohort study from the RECOVER Initiative